Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Hack

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
Journal of Affective Disorders|August 25, 2007
Inflammatory markers in late-life depression: results from a population-based studyM A Bremmer, A T F Beekman, D J H Deeg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Activation of clotting factors XI and IX in patients with acute myocardial infarctionM C Minnema, R J Peters, R de Winter, et al.
Nature Genetics|August 1, 1992
C1 inhibitor hinge region mutations produce dysfunction by different mechanismsA E Davis, K Aulak, R B Parad, et al.
Journal of Immunological Methods|July 6, 1993
Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteinsJ A Kummer, A M Kamp, M van Katwijk, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 7, 2014
Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosisK Budding, E A van de Graaf, T Hoefnagel, et al.
The Journal of Clinical Investigation|August 1, 1989
Proteolytic inactivation of plasma C1- inhibitor in sepsisJ H Nuijens, A J Eerenberg-Belmer, C C Huijbregts, et al.
Blood|February 26, 2000
Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolaseW K Bleeker, J L Teeling, A J Verhoeven, et al.
Blood|February 9, 2000
Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coliM C Minnema, A C Chang, P M Jansen, et al.
Circulation|November 1, 1996
Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulationN Gikakis, M M Khan, Y Hiramatsu, et al.
Journal of Clinical Immunology|September 3, 1999
Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzeesF N Lauw, A A te Velde, P E Dekkers, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Journal of Affective Disorders|August 25, 2007
Inflammatory markers in late-life depression: results from a population-based studyM A Bremmer, A T F Beekman, D J H Deeg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Activation of clotting factors XI and IX in patients with acute myocardial infarctionM C Minnema, R J Peters, R de Winter, et al.
Nature Genetics|August 1, 1992
C1 inhibitor hinge region mutations produce dysfunction by different mechanismsA E Davis, K Aulak, R B Parad, et al.
Journal of Immunological Methods|July 6, 1993
Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteinsJ A Kummer, A M Kamp, M van Katwijk, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 7, 2014
Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosisK Budding, E A van de Graaf, T Hoefnagel, et al.
The Journal of Clinical Investigation|August 1, 1989
Proteolytic inactivation of plasma C1- inhibitor in sepsisJ H Nuijens, A J Eerenberg-Belmer, C C Huijbregts, et al.
Blood|February 26, 2000
Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolaseW K Bleeker, J L Teeling, A J Verhoeven, et al.
Blood|February 9, 2000
Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coliM C Minnema, A C Chang, P M Jansen, et al.
Circulation|November 1, 1996
Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulationN Gikakis, M M Khan, Y Hiramatsu, et al.
Journal of Clinical Immunology|September 3, 1999
Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzeesF N Lauw, A A te Velde, P E Dekkers, et al.
Pageof 37